The London Company, an investment management company, released “The London Company Large Cap Strategy” first quarter 2025 ...

Acumen Pharmaceuticals is advancing in the competitive Alzheimer’s drug development market, focusing on innovative detection and treatment methods. The company completed enrollment for its ...

Methods posters like these are important as they align with our view that a-beta oligomers are the most toxic form of amyloid in the Alzheimer's brain, and help us advancements to such assays and ...

Acumen Pharmaceuticals is advancing in the competitive Alzheimer’s drug development market, focusing on innovative detection and treatment methods. The company completed enrollment for its ALTITUDE AD ...